Technology Integrators in Cell and Gene Therapy: Powering Innovation
Summary: Julien Meissonnier, Catalent’s Vice President and Chief Scientific Officer, discusses innovative approaches, technology disrupters, and more in this webinar.
Creating Commercial-ready & Scalable Solutions for Gene Therapy Development & Manufacturing
Summary: Learn about the complexities from raw material supply through drug product manufacturing, including planning early for a commercial-ready process.
Overcoming Commercialization Challenges for Cell & Gene Therapies
Summary: This panel discussion highlights technical and regulatory hurdles associated with development and manufacturing steps, and strategies and solutions to facilitate development through commercialization.
Clinical Readiness – Practical and Innovative Solutions for AAV Development and Manufacturing
Summary: Learn about specific case studies for neuromuscular degenerative indications, AAV technology and manufacturing, strategies for navigating the current regulatory environments.
Catalent Cell & Gene Therapy, the Journey
Summary: Learn about Catalent’s journey into the Cell and Gene therapy space, overcoming challenges, and the company’s commitment to its partners.
Endpoints Cancer R&D Summit: The Outlook for Cancer Gene Therapies
Summary: What hurdles need to be overcome before gene therapy is the new modality in the cancer therapy arsenal? We’ll look at manufacturing, viral vectors, and the most promising approaches coming to the clinic.